2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow RO6958688: new trials by email Literature Review of RO6958688 trials Research Report on RO6958688
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) Atezolizumab, Cobimetinib, RO6958688 - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | Hoffmann-La Roche | 314 | 2017-12-27 | 2026-05-12 |
| A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors Atezolizumab, RO6958688 - Solid Tumors | Phase 1 | Completed | Hoffmann-La Roche | 228 | 2016-01-07 | 2020-02-12 |
| A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors RO6958688, Obinutuzumab, Tocilizumab - Solid Tumors | Phase 1 | Completed | Hoffmann-La Roche | 149 | 2014-12-30 | 2020-04-17 |
Carcinoma, Non-Small-Cell Lung (1)
France (3) · Spain (3) · United States (3) · Canada (2) · Denmark (2) · Italy (2) · Netherlands (2) · Australia (1) · Israel (1) · South Korea (1) · United Kingdom (1)
2014 (1), 2015 (1), 2017 (1)